Chelatexx (Reformulated Orlistat)
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer of C-103, a reformulated version of orlistat for weight management. Orlistat is marketed in prescription strength by Roche Laboratories (Xenical(R) 120mg capsules) and in over-the-counter strength by GlaxoSmithKline Consumer Healthcare (alli(R) 60mg capsules). Orlistat is an FDA-approved weight management drug for a pediatric population (adolescents 12 years and older).
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 110 Stanbery Ridge
- Fort Thomas, KY 41075
- United States
Chelatexx (Reformulated Orlistat) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Chelatexx (Reformulated Orlistat)‘s full profile, request access.
Request full access to PitchBook